AI assistant
Sending…
GALECTIN THERAPEUTICS INC — Director's Dealing 2011
Apr 13, 2011
33422_dirs_2011-04-13_58c978f2-0713-413d-935c-c2c7a2107d41.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 5 — Annual Statement of Changes in Beneficial Ownership
Issuer: PRO PHARMACEUTICALS INC (PRWP)
CIK: 0001133416
Period of Report: 2010-12-31
Reporting Person: Martin Rod D (Director, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-03-31 | Common Stock | J | 301952 | $0.44 | Acquired | 982783 | Indirect |
| 2010-06-30 | Common Stock | J | 358015 | $0.71 | Acquired | 1340798 | Indirect |
| 2010-09-30 | Common Stock | J | 380475 | $0.79 | Acquired | 1721273 | Indirect |
| 2010-12-31 | Common Stock | J | 380475 | $0.9 | Acquired | 2101748 | Indirect |
Footnotes
F1: Received as dividend on Class B Convertible Preferred Stock held by 10X Fund, LP.
More from GALECTIN THERAPEUTICS INC
Earnings Release
2026
May 15
Interim / Quarterly Report
2026
May 15
Capital/Financing Update
2026
Mar 31
Earnings Release
2026
Mar 31
Annual Report
2026
Mar 31
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17
Board/Management Information
2026
Mar 17
Director's Dealing
2026
Feb 9
Board/Management Information
2026
Jan 21